Health Dictionary Find a Doctor

Tongue cancer primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2] Mohammed Abdelwahed M.D[3]

Overview

Overview

Effective measures for the primary prevention of tongue cancer include avoiding the use of tobacco and excessive use of alcohol. Main methods for prevention are natural components such as: vitamin A, vitamin E, and beta-carotene because they are rich in trace elements and antioxidants. There is a protective effect of diets rich in fresh fruits and vegetables to reduce the incidence of leukoplakia. There is no effective oral cancer screening program either a general or a selected high-risk population for oral cancer in the United States. Screening high-risk individuals in developing countries could be an effective prevention strategy that lowered the stage of oral cancer at diagnosis and improved 5-year survival.

Screening

Screening

  • Tongue cancer screening is not standard procedure for a health assessment.[1]
  • There is no effective oral cancer screening program either a general or a selected high-risk population for oral cancer in the United States.
  • Screening high-risk individuals in developing countries could be an effective prevention strategy that lowered the stage of oral cancer at diagnosis and improved 5-year survival.[2]
  • Screening subjects in the subgroup who used tobacco or alcohol reduced the mortality rate from oral cancer.[3]
Prevention

Prevention

  • Avoiding known risk factors such as the use of tobacco and excessive use of alcohol is the best method of tongue cancer prevention.[4]
  • Main methods for prevention are natural components such as: vitamin A, vitamin E, and beta-carotene beacuse they are rich in trace elements and antioxidants.[5]
  • There is a protective effect of diets rich in fresh fruits and vegetables to reduce incidence of leukoplakia.[6]
  • Toxicity of isotretinoin is the main side effect, particularly in patients treated with doses higher than 2 mg/kg per day.
  • Patients treated at the lower dose level (1 mg/kg per day) had less toxicity and did not require dose reduction.[7]
References

References

  1. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B; et al. (2005). “Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial”. Lancet. 365 (9475): 1927–33. doi:10.1016/S0140-6736(05)66658-5. PMID 15936419.
  2. Santana JC, Delgado L, Miranda J, Sánchez M (1997). “Oral Cancer Case Finding Program (OCCFP)”. Oral Oncol. 33 (1): 10–2. PMID 9192546.
  3. Sankaranarayanan R (1997). “Health care auxiliaries in the detection and prevention of oral cancer”. Oral Oncol. 33 (3): 149–54. PMID 9307722.
  4. Shin DM, Zhang H, Saba NF, Chen AY, Nannapaneni S, Amin AR; et al. (2013). “Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies”. Clin Cancer Res. 19 (5): 1244–56. doi:10.1158/1078-0432.CCR-12-3149. PMC 3693760. PMID 23422093.
  5. Kreimer AR, Chaturvedi AK (2011). “HPV-associated Oropharyngeal Cancers–Are They Preventable?”. Cancer Prev Res (Phila). 4 (9): 1346–9. doi:10.1158/1940-6207.CAPR-11-0379. PMC 3326607. PMID 21893495.
  6. Stich HF, Hornby AP, Mathew B, Sankaranarayanan R, Nair MK (1988). “Response of oral leukoplakias to the administration of vitamin A.” Cancer Lett. 40 (1): 93–101. PMID 3370632.
  7. Wirth LJ, Haddad RI, Lindeman NI, Zhao X, Lee JC, Joshi VA; et al. (2005). “Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck”. J Clin Oncol. 23 (28): 6976–81. doi:10.1200/JCO.2005.02.4182. PMID 16172459.

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH